Hormone therapy for postmenopausal brain performance has no effect, whether started early or late

July 19, 2016 by Bruce Goldman, Stanford University Medical Center
Hormone therapy for postmenopausal brain performance has no effect, whether started early or late
A new study shows that taking estrogen has a negligible effect on the mental skills of postmenopausal women. Credit: Shutterstock/Africa Studio

A study led by a scientist at the Stanford University School of Medicine shows that hormone therapy has a negligible effect on verbal memory and other mental skills regardless of how soon after menopause a woman begins therapy.

The study is the first large, long-term clinical trial to compare the effects of , a type of estrogen, on the mental capabilities of who commence treatment soon after menopause versus those who begin after a long delay.

"Our results suggest that healthy women at all stages after menopause should not take estrogen to improve memory," said the study's senior and lead author, Victor Henderson, MD, professor of health research and policy and of neurology and neurological sciences. "At the same time, they don't need to be overly concerned about negative effects of estrogen on memory."

The study, published online July 18 in Neurology, addresses one specific aspect of a longstanding controversy concerning the benefits and harms of for , whose bodies no longer produce estrogens and as they did during childbearing years.

Doubts about benefits

Hormone therapy was extremely popular in the United States in the latter part of the last century, but its use—while still widespread, with users numbering in the millions—has dropped off considerably since 2002, when findings from the Women's Health Initiative, a large-scale longitudinal study, raised deep doubts about many of what had been believed to be the treatment's broad benefits.

The evidence since then has been mixed on many counts, with a number of small studies, typically relatively short in duration, continuing to suggest potential benefits from hormone therapy. One question is whether the retention of mental abilities—such as memory, reasoning, planning and selective attention—is improved by starting hormone therapy soon after menopause rather than many years later.

The new study is part of a recently completed trial, the Early versus Late Intervention Trial with Estradiol, which enrolled large numbers of postmenopausal women to examine hormone therapy's potential for countering atherosclerosis. One thing ELITE sought to determine was whether outcomes for women taking estradiol, the dominant natural sex steroid in premenopausal women, and progesterone, another steroid involved in the menstrual cycle, would be different than that of women who took Prempro, which was used as part of the Women's Health Initiative in the early 2000s. Prempro is a mixture of modified estrogens derived from mares' urine combined with medroxy-progesterone acetate, a substance whose effects approximate but do not duplicate those of progesterone.

The trial also sought to determine when women should begin hormone therapy to ensure maximal benefits. Depending on the hoped-for clinical outcome, some evidence, mostly from animal studies, suggests that for a woman to benefit from hormone replacement, it may be essential to start soon after menopause, before the rapid postmenopausal decline in estrogen and progesterone availability irreversibly damages hormone-starved cells and tissues.

Estradiol or placebo

For the ELITE trial, which took place at the University of Southern California where Henderson's collaborators are based, healthy postmenopausal women were divided into two groups: an "early group," composed of women whose last menstrual period had occurred no more than six years prior to the start of the study, and a "late group," composed of women whose last period had occurred at least 10 years before the start of the study. Women in the two groups were then randomly assigned to daily oral regimens of either estradiol or a placebo. Estradiol-receiving women who hadn't undergone hysterectomies were also given progesterone, which can help protect against estrogens' uterine-cancer-promoting effect. Women receiving placebo instead of estradiol got a progesterone placebo instead of progesterone.

Henderson and his collaborators received funding to study hormone therapy's effects, over a five-year duration, on these women's cognitive abilities. This adjunct trial, called ELITE-cog, analyzed tests of mental abilities of 567 women between the ages of 41 and 84, representing both the "early" and "late" groups of women. The women's ; their executive functions, such as judgment, planning, reasoning and focusing attention; and their overall neuropsychological condition were assessed at the beginning of the trial and at 2.5 years and five years later.

The difference between the two groups of women on any of these measures was negligible, Henderson and his colleagues found. In fact, there was no appreciable difference in test performance between women receiving estradiol and those given a placebo, regardless of how soon after menopause the women began treatment, the study indicated.

Even when the scientists, in a separate analysis, excluded data from all women in the "early group" who'd begun hormone therapy any later than three years after menopause, they observed neither positive nor negative effects on these women's mental ability compared to that of women initiating treatment more than 10 years after menopause.

Henderson, who is also the director of the Stanford Alzheimer's Disease Research Center, cautions that because women with cognitive deficits or outright dementia were excluded in this analysis, the study's results apply only to women with good mental skills at the time they begin treatment. Also, the findings cannot be extrapolated to cardiovascular or other health outcomes of hormone therapy, which must be assessed individually, he said. Indeed, Henderson noted that there's now some evidence that hormone therapy, initiated early, may have beneficial cardiovascular effects, while it is clear that late hormone therapy can contribute to heart disease.

Hormone therapy during the first five years after the onset of menopause is still approved for relief of moderate-to-severe hot flashes and night sweats, and also has beneficial effects on bone density. "If you're considering hormone therapy for those reasons, this study indicates that there's no particular reason to fear harmful effects on cognition over a five-year period of use," said Henderson. "But there's no reason to expect that this treatment, by itself, will result in meaningful improvement of mental abilities, either."

The work is an example of Stanford Medicine's focus on precision health, the goal of which is to anticipate and prevent disease in the healthy and precisely diagnose and treat disease in the ill.

Explore further: Estrogen patch in newly postmenopausal women may reduce Alzheimer's risk

More information: Victor W. Henderson et al. Cognitive effects of estradiol after menopause, Neurology (2016). DOI: 10.1212/WNL.0000000000002980

Related Stories

Estrogen patch in newly postmenopausal women may reduce Alzheimer's risk

July 12, 2016
Can estrogen preserve brain function and decrease the risk of Alzheimer's disease when given early in menopause? Newly postmenopausal women who received estrogen via a skin patch had reduced beta-amyloid deposits, the sticky ...

Early use of postmenopausal hormone therapy may prevent heart disease

March 30, 2016
Research from Keck School of Medicine at the University of Southern California (USC) suggests that hormone therapy, when taken within six years of menopause, may slow the progression of subclinical atherosclerosis, the buildup ...

Postmenopausal estrogen decline largely unrelated to changes in cognition, mood

November 25, 2013
A new study led by a Stanford University School of Medicine researcher shows that decreased estrogen levels after menopause are largely unrelated to changes in cognitive ability and mood. It did find, however, a possible ...

Genes may determine the side effects of menopausal hormone therapy, study suggests

November 10, 2015
A woman's genes may influence whether hormone therapy after menopause will provide her some protection against heart disease.

Hormone therapy safe for women, study finds

April 18, 2013
(Medical Xpress)—A new study has examined the cognitive effects of hormone therapy on memory, language and concentration in menopausal women.

No improvement in cognition with post-menopausal hormones

June 2, 2015
Menopausal hormone therapy (MHT) given to recently postmenopausal women in the US for up to four years does not improve cognition, but may have some positive benefits for some mood symptoms, according to a study published ...

Recommended for you

Genetic study of epilepsy points to potential new therapies

December 10, 2018
The largest study of its kind, led by international researchers including scientists at RCSI (Royal College of Surgeons in Ireland), has discovered 11 new genes associated with epilepsy.

Team seeks to create genetic map of worm's nervous system

December 10, 2018
How do you build a brain? What "rules" govern where neurons end up, how they connect to each other, and which functions they perform?

Classifying brain microglia: Which are good and which are bad?

December 6, 2018
Microglia are known to be important to brain function. The immune cells have been found to protect the brain from injury and infection and are critical during brain development, helping circuits wire properly. They also seem ...

Drawing is better than writing for memory retention

December 6, 2018
Older adults who take up drawing could enhance their memory, according to a new study.

Friend or foe? Brain area that controls social memory also triggers aggression

December 5, 2018
Columbia scientists have identified a brain region that helps tell an animal when to attack an intruder and when to accept it into its home. This brain area, called CA2, is part of the hippocampus, a larger brain structure ...

How the brain hears and fears

December 5, 2018
How is it that a sound can send a chill down your spine? By observing individual brain cells of mice, scientists at Cold Spring Harbor Laboratory (CSHL) are understanding how a sound can incite fear.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.